How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-Based Approach

The study investigates the effectiveness of baricitinib 4 mg in treating severe alopecia areata (AA) by analyzing the time required to achieve significant hair regrowth. In a post hoc analysis of the BRAVE-AA1/2 trials, patients were categorized based on baseline disease severity and episode duration. Results showed that in severe AA cases (SALT score 50–94), 70% with short duration and 61% with long duration achieved initial improvement (SALT30) by Week 24, with 75% and 65% reaching treatment success (SALT score ≤ 20) by Week 52. In very severe AA cases (SALT score 95–100), 42% with short duration and 25% with long duration achieved SALT30 by Week 24, leading to 58% and 43% achieving treatment success by Week 52. The findings suggest that treatment should continue for at least 1 year before determining failure, especially in very severe cases.